Purchase Order W81K0018P0059

Award Date 12/21/17
Potential Completion Date 9/30/22
Potential Value $538K
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cypress, CA 90630, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Davis Bacon Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Diasorin Molecular LLC, a foreign-owned for-profit manufacturer of medical diagnostic products and testing equipment. The contract, valued at $337,734.52, is to provide COVID-19 molecular diagnostic tests, reagents, and laboratory instrumentation to support infectious disease testing and surveillance at VA hospitals and clinics across various Veterans Integrated Service...
This firm-fixed-price delivery order was awarded by the Department of Veterans Affairs Veterans Health Administration to Diasorin Molecular, LLC, a foreign-owned manufacturer of medical diagnostic products and testing equipment. The $11,688 contract provides COVID-19 tests, analyzers, and related laboratory equipment and maintenance services to support the agency's pandemic response efforts across VA medical centers. Diasorin Molecular, LLC is a prime contractor on several federal contracts with...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a delivery order to Diasorin Molecular, LLC, a foreign-owned for-profit manufacturer of medical diagnostic products and testing equipment, to provide COVID-19 test kits. The firm-fixed-price contract, valued at $159,143.26, was issued under a VA Veterans Integrated Service Network 23 (VISN 23) contract vehicle without any set-aside designation. Diasorin Molecular has previously provided COVID-19, influenza,...
This is a firm-fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Diasorin Molecular LLC, a foreign-owned for-profit manufacturer of medical diagnostic products and testing equipment. The contract, valued at $73,226.83, is for Diasorin's Simplexa molecular diagnostic tests and analyzers to support COVID-19 testing and surveillance at VA medical facilities in California and Minnesota. The contract is not set aside and was issued under a...
The U.S. Department of Veterans Affairs (VA) Veterans Health Administration awarded a delivery order to Diasorin Molecular LLC, a for-profit manufacturer of medical diagnostics, for the provision of COVID-19 tests. The $173,516.52 firm-fixed price contract does not have a set-aside designation and was issued under an existing Indefinite Delivery/Indefinite Quantity (IDIQ) contract by VA's Veterans Integrated Service Network (VISN) 23. Diasorin Molecular, which is a foreign-owned company, has...
The U.S. Department of Veterans Affairs (VA) awarded a Delivery Order contract worth $28,316.49 to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment. The contract is to provide COVID-19 tests and analyzers to support the VA's pandemic response efforts across its Veterans Integrated Service Network (VISN) 23. Diasorin Molecular has previously been awarded several Indefinite Delivery Vehicle (IDV) contracts by the VA to supply...
Diasorin Molecular LLC has been awarded a firm-fixed price purchase order by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 for $220,040.76 to provide Diasorin reagents and supplies for COVID-19 testing through December 2022. The award was issued on December 21, 2021 without a set-aside designation. Diasorin Molecular LLC will deliver the requested reagents and supplies to support coronavirus disease testing at VA medical facilities in...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 10 (VISN 10) to Diasorin Molecular, LLC, a foreign-owned, for-profit manufacturer of medical diagnostic products and testing equipment. The $552,071.87 firm fixed-price purchase order is for the delivery of Simplexa COVID-19 Direct Kits and Simplexa COVID-19 Positive Control Packs through October 31, 2026. This sole-source award was made under simplified...
This federal contract award to Diasorin Molecular LLC, a foreign-owned for-profit manufacturer of medical diagnostic products, is for the provision of the LIAISON MDX System and related reagents to the U.S. Department of Veterans Affairs (VA) Veterans Health Administration. The $101,552 firm-fixed-price purchase order, which was not set aside, supports the VA's COVID-19 pandemic response efforts. Through this and other contracts, Diasorin Molecular LLC has supplied COVID-19 diagnostic tests,...
This contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Diasorin Molecular LLC, a for-profit manufacturer of medical diagnostic products and testing equipment. The $225,508.09 firm-fixed price purchase order is for the provision of DiaSorin reagents and consumables to support infectious disease testing and surveillance at VA medical facilities. The contract was awarded without any set-aside designation. Through this and other VA contracts,...

The Department of the Army Medical Command awarded a firm-fixed price purchase order contract to Diasorin Molecular LLC, a foreign-owned for-profit manufacturer of medical diagnostic products and testing equipment. The $537,535.00 contract is for chemistry testing services, with a completion date of September 30, 2022. Diasorin Molecular LLC has provided molecular diagnostic tests, reagents, and laboratory instrumentation to support infectious disease testing and surveillance for the Department of Veterans Affairs (VA) and the Department of Health and Human Services (HHS), including for COVID-19, influenza, respiratory syncytial virus, herpes, and cytomegalovirus. The contract was awarded without the use of a set-aside.

Generated 3/24/24, 3:44 AM